Table 1.

Effects of antiapoptotic constructs and pharmacologic inhibitors on CD40L- and T-cell—mediated death of IκBαAA-transfected DCs



Prevention of death mediated by

CD40L
T cells plus sAg
Constructs*   
    A1  ++   ++  
    Bcl-2  ++   ++  
    Bcl-xL  ++   ++  
    cFlip  +   +  
    IEX-1  +   +  
    API1/HIAP2  -   -  
    API2/HIAP1  -   -  
    API3/XIAP  -   -  
    AP14/survivin  -   -  
    A20  -   -  
    Gadd45β  -   ND  
Pharmacologic inhibitors   
    Caspase-3 inh.   ++   ND  
    Caspase-8 inh.
 
-
 
ND
 


Prevention of death mediated by

CD40L
T cells plus sAg
Constructs*   
    A1  ++   ++  
    Bcl-2  ++   ++  
    Bcl-xL  ++   ++  
    cFlip  +   +  
    IEX-1  +   +  
    API1/HIAP2  -   -  
    API2/HIAP1  -   -  
    API3/XIAP  -   -  
    AP14/survivin  -   -  
    A20  -   -  
    Gadd45β  -   ND  
Pharmacologic inhibitors   
    Caspase-3 inh.   ++   ND  
    Caspase-8 inh.
 
-
 
ND
 

Modified DCs were cultured in the absence or in the presence of CD40L or autologous CD4+ T cells plus sAg, and viable DCs were counted 3 days later using FACS. Survival of control-transfected DCs and of IκBαAA-transfected DCs in the presence of CD40L or T cells was set to 100% and 0%, respectively. (++) Rescue of survival of 50% or more to 100%, (+) of 10% or more to 50%, and (-) of less than 10% in CD40L-exposed (left column) and T cell/sAg-exposed (right column) DCs. Results are representative of 2 to 4 independent experiments.

ND indicates not determined.

*

Indicated transgenes or empty vector only were cotransfected with IκBαAA or control vector.

Alternatively, IκBαAA- or control vector—transfected DCs were incubated with the indicated caspase inhibitors (20 μM each).

Close Modal

or Create an Account

Close Modal
Close Modal